CeriBell, Inc. (CBLL) 是一家上市公司 屬於 醫療保健 板塊，經營於 Medical - Devices 產業. 公司總部位於 Sunnyvale, CA, 美国. 現任CEO為 Xingjuan Chao.
CBLL 擁有 IPO日期為 2024-10-11, 281 名全職員工, 在 NASDAQ Global Select, 市值為 $772.77M.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
